Editor-in-Chief
Hong Zhao, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
Editorial Board Members
Amar U. Kishan, University of California, Los Angeles, Los Angeles, United States
Arya Amini, City of Hope National Medical Center, Duarte, United States
Avirup Guha, Augusta University, Augusta, United States
Behzad Baradaran, Tabriz University of Medical Sciences, Tabriz, Iran
Bonglee Kim, Kyung Hee University, Seoul, Republic of Korea
David J. Pinato, Imperial College London, London, United Kingdom
Debraj Mukherjee, Johns Hopkins School of Medicine, Baltimore, United States
Efsun Somay, Baskent University, Ankara, Turkey
Emre Gorgun, Cleveland Clinic, Digestive Disease and Surgery Institute, Cleveland, United States
Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Florian J. Fintelmann, Massachusetts General Hospital, Boston, United States
Fumihiko Urabe, The Jikei University School of Medicine, Tokyo, Japan
Giorgio Treglia, Università della Svizzera Italiana, Lugano, Switzerland
Hardeep Singh Tuli, Maharishi Markandeshwar (Deemed to be University, MMDU), Ambala, India
Ithaar H. Derweesh, University of California San Diego, San Diego, United States
Jason J. Luke, UPMC Hillman Cancer Center, Pittsburgh, United States
Jennifer K. Plichta, Duke University Medical Center, Durham, United States
Juan P. Cata, The University of Texas MD Anderson Cancer Center, Houston, United States
Jung-Yun Lee, Yonsei University College of Medicine, Seoul, South Korea
Kah Poh Loh, University of Rochester Medical Center, Rochester, United States
Kjetil Søreide, Stavanger University Hospital, Stavanger, Norway
Manisha Bahl, Massachusetts General Hospital, Boston, United States
Massimo Di Maio, University of Turin, Turin, Italy
Mohammad Taheri, Jena University Hospital, Jena, Germany
Mohit Kumar Jolly, Indian Institute of Science, Bengaluru, India
Nicolas Girard, Institut Curie, Paris, France
Nicola Fusco, European Institute of Oncology IRCCS, Milan, Italy
Nicholas J. Short, The University of Texas MD Anderson Cancer Center, Houston, United States
Pascal A. T. Baltzer, Medical University of Vienna, Vienna, Austria
Raluca-Ioana Stefan-van Staden, Laboratory of Electrochemistry and PATLAB, Bucharest, Romania
Sara Pilotto, University of Verona, Verona, Italy
Seyed Morteza Naghib, Iran University of Science and Technology (IUST), Tehran, Iran
Soichiro Yoshida, Institute of Science Tokyo, Tokyo, Japan
Sumanta Kumar Pal, City of Hope Comprehensive Cancer Center, Duarte, United States
Takayuki Yoshino, National Cancer Center Hospital East, Kashiwa, Japan
Vivek Subbiah, The University of Texas MD Anderson Cancer Center, Houston, United States
The editorial board is currently being established. The listed experts have been invited or are in discussion to join